<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Among the locations of <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo>, even if rare, <z:hpo ids='HP_0005305'>cerebral-vein thrombosis</z:hpo> is a severe event with a high mortality rate </plain></SENT>
<SENT sid="1" pm="."><plain>No aetiology is found in 20 to 30% of the cases </plain></SENT>
<SENT sid="2" pm="."><plain>In recent years, <z:e sem="disease" ids="C0852077" disease_type="Disease or Syndrome" abbrv="">inherited coagulation disorders</z:e> have been described, as risk factors for <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>We report the results of a retrospective study of 27 patients who suffered <z:hpo ids='HP_0005305'>cerebral-vein thrombosis</z:hpo>, in which <z:hpo ids='HP_0001928'>coagulation abnormalities</z:hpo> have been searched for </plain></SENT>
<SENT sid="4" pm="."><plain>METHOD: The patients were referred to the haemostasis laboratory of the Henri <z:e sem="disease" ids="C0265070" disease_type="Disease or Syndrome" abbrv="">Mondor</z:e> hospital between august 1982 and June 1988, after a <z:hpo ids='HP_0005305'>cerebral-vein thrombosis</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The predisposing factors, personal and family history of <z:hpo ids='HP_0001907'>thromboembolism</z:hpo>, clinical presentation, <z:mp ids='MP_0005048'>thrombosis</z:mp> location, evolution under treatment and long-term outcome, have been noted </plain></SENT>
<SENT sid="6" pm="."><plain>Deficiencies in antithrombine, protein C, protein S, the Factor V Leiden and the G20210A prothrombin-gene mutation, the presence of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>, of anticardiolipin antibodies as well as a <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinaemia</z:e> have been searched, either at the initial presentation, or a posteriori </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Fourty-one percent of patients had a <z:hpo ids='HP_0001928'>coagulation abnormality</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>The prevalence of the different abnormalities was: inherited deficiency in AT 7.4%, in PC 8%, in PS 12.5%, <z:e sem="disease" ids="C0584960" disease_type="Disease or Syndrome" abbrv="">factor V Leiden mutation</z:e> 12%, G20210A prothrombin-gene mutation 12% </plain></SENT>
<SENT sid="9" pm="."><plain>Two patients had combined defects: AT and <z:e sem="disease" ids="C0034341" disease_type="Disease or Syndrome" abbrv="">PC deficiency</z:e> in one, F V Leiden and F II G20210A mutations in one. e of the patient had <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> </plain></SENT>
<SENT sid="10" pm="."><plain>Three patients had a significant rate of anticardiolipin antibodies </plain></SENT>
<SENT sid="11" pm="."><plain>Five patients out of eight displayed a moderate <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinaemia</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Nothing (past history, age, predisposing factors) distinguished those patients bearing a <z:e sem="disease" ids="C0005779" disease_type="Disease or Syndrome" abbrv="">coagulation disorder</z:e> from the others </plain></SENT>
<SENT sid="13" pm="."><plain>The venous thromboembolic relapse rate of 15 % (4/27 patients) </plain></SENT>
<SENT sid="14" pm="."><plain>Three of them had an inherited thrombophilic abnormality </plain></SENT>
<SENT sid="15" pm="."><plain>CONCLUSION: We recommend an investigation of the haemostasis after every <z:hpo ids='HP_0005305'>cerebral venous thrombosis</z:hpo> </plain></SENT>
</text></document>